United States · FDA National Drug Code directory
Cefdinir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-2719_ea6d412a-1b6c-4291-b13b-38ba666d8bb6
- Product NDC
- 50090-2719
- Form
- CAPSULE
- Composition / generic term
- Cefdinir
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080107
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFDINIR — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 CAPSULE in 1 BOTTLE (50090-2719-0) · 50090-2719-0
- 20 CAPSULE in 1 BOTTLE (50090-2719-1) · 50090-2719-1
- 14 CAPSULE in 1 BOTTLE (50090-2719-2) · 50090-2719-2
- 30 CAPSULE in 1 BOTTLE (50090-2719-3) · 50090-2719-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →